PR NEWSWIRE

Previous Stories

JinkoSolar Launched the Residential Energy Storage System “SUNTANK” in Australia

Jul 22 2022 - PR NewsWire

SYDNEY, July 22, 2022 /PRNewswire/ – Recently, Jinko Solar Australia Holding Co PTY. LTD., one of the largest and most innovative…


VisionNav debuts Autonomous Forklift at CeMAT Australia 2022

Jul 22 2022 - PR NewsWire

MELBOURNE, Australia, July 22, 2022 /PRNewswire/ – As a key part of its global tour, VisionNav debuts its iconic autonomous forklift…


Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Mul

Jul 21 2022 - PR NewsWire

– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive…


Binance Australia Derivatives successfully launches crypto CFDs under an Australian Financial Services Licence

Jul 21 2022 - PR NewsWire

SYDNEY and NEW SOUTH WALES, Australia, July 21, 2022 /PRNewswire/ — Binance Australia Derivatives has launched over-the-counter (OTC) derivative products,…


Telix Reports Second Quarter 2022 Financial Results

Jul 21 2022 - PR NewsWire

MELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly…


Airwallex launches Online Payments App on Shopify

Jul 21 2022 - PR NewsWire

MELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Airwallex, a leading global fintech platform, announced the launch of its Airwallex Online…


Former Australian Prime Minister and Former Alcoa COO Join GlassPoint’s Advisory Board

Jul 21 2022 - PR NewsWire

New advisory board members will help solar steam leader meet the soaring demand for industrial decarbonization NEW YORK, July 21,…


Recruitment complete for Clarity’s PROPELLER prostate cancer diagnostic trial

Jul 20 2022 - PR NewsWire

SYDNEY, July 20, 2022 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address…


VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model – Before or After Viral Exposure

Jul 20 2022 - PR NewsWire

MELBOURNE, Australia, July 20, 2022 /PRNewswire/ – Starpharma’s broad-spectrum VIRALEZE™ nasal spray has shown protection against infection with the highly transmissible SARS-CoV-2…


XPON ACHIEVES CERTIFICATION AS A GREAT PLACE TO WORK IN 2022

Jul 20 2022 - PR NewsWire

NEWSTEAD, Australia, July 20, 2022 /PRNewswire/ – XPON Technologies Group Ltd (ASX: XPN) (XPON or the Company), a founder-led Marketing Technology…


Analyse The Market From A Different Angle